{"mainPropery":{"diseaseId":6042,"diseaseName":"Intrahepatic cholangiocarcinoma","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/6042/intrahepatic-cholangiocarcinoma","synonyms":[],"synonyms-with-source":[],"identifiers":[{"identifierType":"UMLS","identifierId":"C0345905"}]},"diseaseCategories":[{"diseaseTypeId":1,"diseaseTypeName":"Rare Cancers"}],"organizations":[{"resourceID":3094,"resourceName":"Cholangiocarcinoma Foundation","abbreviation":"","address1":"5526 West 13400 South, #510","address2":"","address3":"","address4":"","address5":"","city":"Salt Lake City","state":"UT","zip":"84096","country":"","phone":"(801) 999-0455","tty":"","tollFree":"","fax":"","email":"info@cholangiocarcinoma.org","url":"http://cholangiocarcinoma.org/"}],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=PureSearch&db=pubmed&details_term=%22Cholangiocarcinoma%22%5BMeSH%5D%20AND%20%28%22human%22%5BMeSH%20Terms%5D%20OR%20%22hominidae%22%5BMeSH%20Terms%5D%29%20AND%20%221999/10/28%2016.03%22%5BEDAT%5D%20%3A%20%222004/10/26%2016.03%22%5BEDAT%5D' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Intrahepatic cholangiocarcinoma. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Intrahepatic+cholangiocarcinoma%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Intrahepatic cholangiocarcinoma. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='https://ghr.nlm.nih.gov/condition/cholangiocarcinoma' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Intrahepatic cholangiocarcinoma. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":102,"resourceId":120,"resourceName":"American Cancer Society","descriptionText":"The <a href='http://www.cancer.org/acs/groups/cid/documents/webcontent/003084-pdf.pdf' target='_blank'>American Cancer Society </a> provides information on Intrahepatic cholangiocarcinoma. Please click on the link to access this resource.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":708,"resourceId":1403,"resourceName":"Cancers of liver and biliary tract","descriptionText":"Key C and Meisner ALW. <a href='http://seer.cancer.gov/publications/survival/surv_liver.pdf ' target='_blank'>Chapter 6: Cancers of the Liver and Biliary Tract. National Cancer Institute</a>. SEER Survival Monograph.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":749,"resourceId":1434,"resourceName":"Intrahepatic cholangiocarcinoma","descriptionText":"Aljiffry M, Walsh MJ, Molinari M. <a href='http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2744180/pdf/WJG-15-4240.pdf ' target='_blank'>Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009</a>. World J Gastroenterol. 2009 Sep 14;15(34):4240-62. [PDF]","resourceClassificationName":"Overview","resourceClassificationSectionName":"Selected Full-Text Journal Articles"},{"id":1532,"resourceId":2163,"resourceName":"Social Security Administration","descriptionText":"The <a href='https://secure.ssa.gov/apps10/poms.nsf/lnx/0423022175' target='_blank'>Social Security Administration</a> has included this condition in their Compassionate Allowances Initiative. This initiative speeds up the processing of disability claims for applicants with certain medical conditions that cause severe disability. More information about <a href=\"http://www.ssa.gov/compassionateallowances/index.htm\" target=\"_blank\">Compassionate Allowances</a> and <a href=\"https://www.ssa.gov/benefits/disability/\" target=\"_blank\">applying for Social Security disability</a> is available online.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"},{"id":1543,"resourceId":2171,"resourceName":"National Cancer Institute","descriptionText":"The <a href='http://www.cancer.gov/cancertopics/pdq/treatment/adult-primary-liver/Patient' target='_blank'>National Cancer Institute</a> provides the most current information on cancer for patients, health professionals, and the general public.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/DOID:4928' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":7416,"questionText":"What is intrahepatic cholangiocarcinoma?","answerText":"<strong>Intrahepatic cholangiocarcinoma</strong> is a cancer that develops in the cells within the bile ducts; both inside and outside the liver. The terms cholangiocarinoma and bile duct cancer are often used to refer to the same condition. This condition occurs slightly more often in males than females and usually affects people who are between 50-70 years old. Signs and symptoms of intrahepatic cholangiocarcinoma include jaundice, abdominal pain, fever, weight loss, weakness and itching. Treatment options may include&nbsp;surgery to remove the bile duct and parts of the liver, chemotherapy and radiation.[7319]","dateModified":"2014-04-01T11:44:00"},"basicQuestions":[{"questionId":7417,"questionText":"How might intrahepatic cholangiocarcinoma be treated? Can it be cured?","answerText":"Surgery to completely remove the bile duct and tumor is the only option that can possibly lead to a cure for patients. The type of operation will depend on the size and location of the cancer. For cases of intrahepatic cancers that cannot be surgically removed, a liver transplantation may be an option. In some cases, a liver transplant might even cure the cancer. Finally, radiation and chemotherapy are also treatment options available for intrahepatic cholangiocarcioma either in addition to surgery or on their own.[7320]","dateModified":"2014-04-01T12:09:00","resourceClassificationName":"Treatment","references":[{"referenceId":7320,"authors":"","articleTitle":"Bile Duct Cancer (Cholangiocarcinoma)","bookWebsiteJournalTitle":"American Cancer Society","date":"October 30, 2013","volume":"","pages":"","url":"http://www.cancer.org/acs/groups/cid/documents/webcontent/003084-pdf.pdf","dateAccessed":"2014-04-01T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[{"referenceId":7320,"authors":"","articleTitle":"Bile Duct Cancer (Cholangiocarcinoma)","bookWebsiteJournalTitle":"American Cancer Society","date":"October 30, 2013","volume":"","pages":"","url":"http://www.cancer.org/acs/groups/cid/documents/webcontent/003084-pdf.pdf","dateAccessed":"2014-04-01T00:00:00","authors2":"","placeOfPublication":"","publisher":""}],"relatedDiseases":[{"relatedDiseaseId":6608,"relatedDiseaseName":"Primary liver cancer","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[{"caseId":44665,"abbreviatedInquiry":"Is there a cure for this horrible disease? Also are there any new research trials going on now for people recently diagnosed with this disease?","caseQuestions":[{"questionId":7416,"questionText":"What is intrahepatic cholangiocarcinoma?","answerText":"<strong>Intrahepatic cholangiocarcinoma</strong> is a cancer that develops in the cells within the bile ducts; both inside and outside the liver. The terms cholangiocarinoma and bile duct cancer are often used to refer to the same condition. This condition occurs slightly more often in males than females and usually affects people who are between 50-70 years old. Signs and symptoms of intrahepatic cholangiocarcinoma include jaundice, abdominal pain, fever, weight loss, weakness and itching. Treatment options may include&nbsp;surgery to remove the bile duct and parts of the liver, chemotherapy and radiation.[7319]","dateModified":"2014-04-01T11:44:00","references":[{"referenceId":7319,"authors":"","articleTitle":"Bile Duct Cancer (Cholangiocarcinoma)","bookWebsiteJournalTitle":"Johns Hopkins Medicine Liver Tumor Center","date":"","volume":"","pages":"","url":"http://www.hopkinsmedicine.org/liver_tumor_center/conditions/bile_duct_cancer.html","dateAccessed":"2014-04-01T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":7417,"questionText":"How might intrahepatic cholangiocarcinoma be treated? Can it be cured?","answerText":"Surgery to completely remove the bile duct and tumor is the only option that can possibly lead to a cure for patients. The type of operation will depend on the size and location of the cancer. For cases of intrahepatic cancers that cannot be surgically removed, a liver transplantation may be an option. In some cases, a liver transplant might even cure the cancer. Finally, radiation and chemotherapy are also treatment options available for intrahepatic cholangiocarcioma either in addition to surgery or on their own.[7320]","dateModified":"2014-04-01T12:09:00","resourceClassificationName":"Treatment","references":[{"referenceId":7320,"authors":"","articleTitle":"Bile Duct Cancer (Cholangiocarcinoma)","bookWebsiteJournalTitle":"American Cancer Society","date":"October 30, 2013","volume":"","pages":"","url":"http://www.cancer.org/acs/groups/cid/documents/webcontent/003084-pdf.pdf","dateAccessed":"2014-04-01T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":7418,"questionText":"How can I find out about clinical research studies involving intrahepatic cholangiocarcinoma?","answerText":"<a href=\"http://www.clinicaltrials.gov/ct2/results?cond=%22Intrahepatic+cholangiocarcinoma%22\" target=\"_blank\">ClinicalTrials.gov</a> lists trials that are studying or have studied Intrahepatic cholangiocarcinoma. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.After you click on a study, review its \"eligibility\" criteria to determine its appropriateness. Use the study&rsquo;s contact information to learn more. Check this site often for regular updates.","dateModified":"2014-04-01T12:15:00","references":[]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[],"EncodedName":"Intrahepatic_cholangiocarcinoma"}